Official Title
The Effect of EXPAREL® on Postsurgical Pain, and the Use of Narcotics
Phase
Phase 4Lead Sponsor
Andrews Research & Education FoundationStudy Type
InterventionalStatus
SuspendedIndication/Condition
Rotator Cuff TearIntervention/Treatment
EXPAREL 1.3 % in 20 ML InjectionStudy Participants
60Patients undergoing shoulder rotator cuff surgery in an outpatient setting are the focus of this study. The purpose of this study is to determine if the product EXPAREL® can be used as a safe alternative in shoulder surgery to pain pumps, while limiting narcotic use and providing appropriate postoperative pain control.
Based on prior research, it is hypothesized EXPAREL® can potentially be used as a local anesthetic option after undergoing an arthroscopic rotator cuff repair in the outpatient setting. Conducting this study, will allow the option for a surgeon to administer a local anesthetic, in a single injection, to the exact location of the surgical procedure and in a sterile environment. The purpose of this pilot study is to determine if EXPAREL® can be used as a safe alternative to current post-operative pain control methods, while limiting narcotic use and providing appropriate postoperative analgesia.
EXPAREL single shot dose given as an analgesia for arthroscopic rotator cuff repair surgery.
EXPAREL (bupivacaine liposome injectable suspension, 20 mL single use vial, 1.3% [13.3 mg/mL]) is a liposome injection of bupivacaine, an amide local anesthetic, indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. EXPAREL dosage is based on the following factors: size of surgical site volume required to cover the area individual patient factors that may impact the safety of an amide local anesthetic maximum doe of 266 mg (20 mL)
Inclusion Criteria: Male or female 18-72 years of age Subjects scheduled to undergo a rotator cuff repair with a subacromial decompression by one of the protocol investigators Exclusion Criteria: Planned concomitant glenoid labral repair Previous open shoulder surgery Neurological deficit or other disability involving the surgical extremity Anyone with a documented allergy to bupivicaine Subjects that are not mentally competent to give consent Pregnant women Subjects with an intolerance to hydrocodone or oxycodone and/or brand name equivalent combination medication